Getinge Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Go Beyond the Preview – Access the Full Value Chain Analysis
This Getinge Value Chain Analysis provides a clear, company-specific view of how Getinge creates value through its support and primary activities. The page already includes a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to access the complete ready-to-use report.
Support Activities
Firm Infrastructure
Getinge's firm infrastructure centers on corporate, legal, quality, and risk controls that keep its regulated medtech portfolio aligned across regions. This matters for a business that serves hospitals, life science customers, and manufacturing sites under one compliance standard. Centralized governance also helps Getinge manage product quality and audit readiness across a global footprint.
Human Resource Management
Getinge's Human Resource Management depends on engineers, clinical specialists, service technicians, and quality staff who can handle complex medical equipment in hospitals. In 2025, Getinge employed about 12,000 people, so training and retention are key to protect service quality and uptime. A skilled field team helps Getinge install, maintain, and support devices safely, and that directly supports recurring service revenue.
Technology Development
Getinge's technology development centers on R&D for ICU, cardiovascular, operating room, sterile reprocessing, and biopharma systems, where software, connectivity, and validation help speed workflows and support premium pricing. In FY2025, this matters because the medtech market keeps shifting toward integrated digital platforms, and Getinge's product mix is built around that demand. One line: better tech here protects margin and keeps customers locked in.
Procurement
In 2025, Getinge kept procurement focused on qualified suppliers for precision components, electronics, metals, and consumables. Tight supplier control helps protect product quality and steady supply in regulated medtech, where a missed part can slow output and uptime. It also supports cost discipline by limiting defects, rework, and supply shocks across Getinge's production base.
Getinge's FY2025 support engine kept quality, supply, and uptime on track
Getinge's support activities in FY2025 were built to keep a regulated medtech base stable: tight governance, skilled staff, R&D, and supplier control. With about 12,000 employees, training and retention stayed central to service quality and uptime. R&D and qualified sourcing helped protect product quality, margin, and supply continuity.
| FY2025 data | Getinge |
|---|---|
| Employees | ~12,000 |
| Support focus | Governance, R&D, procurement |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Getinge inbound logistics depends on traceable, inspected supply channels for regulated parts and materials, because sterile reprocessing and high-acuity devices need tight component control. Incoming quality checks cut the risk of defects reaching production, which protects clinical reliability and supports compliance. In FY2025, this step stayed critical as even a single faulty input can disrupt output, delay delivery, and raise rework costs.
Operations
In 2025, Getinge turned engineering into dependable output by assembling, testing, and validating complex systems for hospitals and life science sites. Its manufacturing discipline matters because Getinge reported net sales of about SEK 33.8 billion in 2025, so small cuts in rework, downtime, and warranty claims can protect a large revenue base. The same control also supports quality and uptime in critical care equipment, where failures are costly and visible.
Outbound Logistics
Getinge's outbound logistics moves finished systems, spare parts, and consumables through global distribution networks, with regional warehousing and customs handling to keep hospital and biopharma deliveries on time. For large systems, installation planning is built into shipment timing, which cuts delay risk at the site. In 2025, this matters more as Getinge served customers in 40+ countries and kept service parts close to demand.
Marketing and Sales
Getinge uses direct sales, tenders, and clinical value messaging to reach hospitals, operating rooms, ICUs, and biopharma sites. This model fits high-acuity buys, where buyers pay for workflow gains and outcomes, not just price. In 2025, that approach helped Getinge push higher-spec equipment by tying the sale to lower downtime, safer care, and better throughput.
Service
Getinge's service activity covers installation, training, maintenance, repair, and spare parts for its medical systems. This keeps critical equipment running, cuts downtime, and supports customer loyalty after the initial sale. Service also adds recurring revenue, which can smooth earnings when new equipment demand slows.
Getinge's FY2025 engine: SEK 33.8B sales powered by service and global reach
Getinge's primary activities in FY2025 turned regulated inputs into 2025 net sales of SEK 33.8 billion through controlled manufacturing, validation, and testing. Its global distribution kept devices, spare parts, and consumables close to hospitals and biopharma sites, while direct sales and tendering supported high-acuity wins. Installation, training, and service then protected uptime and recurring revenue.
| Primary activity | FY2025 fact |
|---|---|
| Operations | SEK 33.8 billion net sales |
| Service | Installation, training, repair, spare parts |
What You See Is What You Get
Getinge Reference Sources
This is the actual Getinge Value Chain Analysis document you'll receive upon purchase – no surprises, just professional quality. The preview below is taken directly from the full report, so what you see here is exactly what you'll download after checkout. Purchase unlocks the complete, in-depth version.
Frequently Asked Questions
It focuses on how Getinge turns 5 solution areas into value through 4 support activities and 5 primary activities. The model highlights regulated manufacturing, sales execution, and post-sale service across 2 end markets: healthcare and life science facilities. That is where workflow efficiency and clinical reliability become commercial advantage.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.